The Medical Advisor

Ivermectin Resources Recently, I have seen tremendous demand for some sort of initial guidance “WHERE TO START” with High Dose Ivermectin for CANCER. Editor's Note: Dr Makis proposes four distinct cancer protocols for using Ivermectin in cancer treatment, specifically for patients who have developed turbo cancer or aggressive cancers. These protocols, referred to as the “Dr. Makis Ivermectin Cancer Protocols,” are categorized based on dosage and the severity of the cancer. Updated version I have an article and a video that go into depth: June 10, 2024 - "15 minutes with Dr.Makis" - Episode 018: High Dose Ivermectin and Cancer .  2025 studies on ivermectin for cancer Yuan Yuan et al (Cedars-Sinai Medical Center) - A phase I/II study evaluating the safety and efficacy of ivermectin in combination with balstilimab in patients with metastatic triple negative breast cancer (ASCO 2025) Yuwen et al -  A Review of Ivermectin Use in Cancer Patients: Is it Time to Repurpose the Ive...

Introduction Cancers of the female reproductive system, including ovarian, endometrial (uterine), and cervical cancers, represent a significant global health burden, often presenting at advanced stages with limited treatment options and poor prognosis. Conventional therapies such as chemotherapy, radiation, and surgery, while effective in some cases, frequently fail in recurrent or metastatic disease, prompting exploration of drug repurposing strategies.  This compilation examines emerging case reports on the off-label use of antiparasitic agents—primarily ivermectin and fenbendazole, alongside related benzimidazoles like mebendazole—in managing these malignancies. Drawing from 19 documented cases, the article categorizes outcomes by cancer type and integrates mechanistic insights from preclinical studies, where these compounds have demonstrated antitumor effects such as microtubule disruption, inhibition of oncogenic signaling pathways (e.g., PAK1, Wnt/β-catenin), induction of apo...